Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often highlight the opportunity for meaningful therapeutic gains, principally in conditions where conventional treatments have proven limited. However, this is to assess the substantial financial investment associated with CPI stem cell the